Pitx Factors Are Involved in Basal and Hormone-regulated Activity of the Human Prolactin Promoter*

M. Quentien,I. Manfroid,D. Moncet,G. Gunz,M. Muller,M. Grino,A. Enjalbert,I. Pellegrini
DOI: https://doi.org/10.1074/JBC.M207824200
IF: 5.485
2002-11-15
Journal of Biological Chemistry
Abstract:The pituitary-specific POU homeodomain factor Pit-1 likely interacts with other factors for cell-specific expression of prolactin. Here we identify the paired-like homeobox transcription factors Pitx1 and Pitx2 as factors functionally activating the proximal human prolactin promoter (hPRL-164luc). Using in vitrobinding assays and a series of site-specific mutations of the proximalhPRL promoter, we mapped the B1 and B2 bicoid sites involved in Pitx-mediated transactivation of the hPRL-164luc construct. In somatolactotroph GH4C1 cells, basal proximal hPRLpromoter activity was inhibited by a Pitx2 dominant-negative form in a dose-dependent manner, whereas binding disruptive mutations in the Pitx sites significantly reduced basal activity of the promoter. We also show that synergistic activation of hPRL-164luc by Pitx2 and Pit-1 requires the integrity of the B2 Pitx binding site, and at least one of the P1 and P2 Pit-1 response elements. In addition, mutation in the B2 Pitx site results in attenuation of the promoter's responsiveness to forskolin, thyrotropin-releasing hormone, and epidermal growth factor. Conversely, Pitx1 or Pitx2 overexpression in GH4C1 cells leads to an enhancement of the drugs stimulatory effects. Altogether, these results suggest that full responsiveness to several signaling pathways regulating the hPRL promoter requires the B2 Pitx binding site and that Pitx factors may be part of the proteic complex involved in these regulations. Finally, in situ hybridization analysis showing coexpression of thePRL and Pitx2 genes in rat and human lactotroph cells corroborates the physiological relevance of these results.
What problem does this paper attempt to address?